reviews on oral semaglutide A Review Semaglutide: An Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy Oral Semaglutide: Weight Loss &

A protocol followed reliably will outperform a theoretically optimal schedule that gets interrupted or forgotten

Theyre not interchangeable

Post-marketing surveillance and clinical case series provide better signal

Exposure was approximately twofold higher with a 40 mg versus a 20 mg dose, and there was no difference in exposure for the 40 mg dose between healthy individuals and those with T2D

The cardioprotective function of exendin-4 during hyperglycemic states was further elaborated in a recent study conducted by Younce, whereby exendin-4 was found to improve cardiac function by inhibiting thapsigargin-mediated decrease in SERCA2a mRNA and via active phosphorylation of phospholamban [59]